Detalles de la búsqueda
1.
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success.
Curr Oncol Rep
; 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38850505
2.
The case for adjuvant BRAF-targeted therapy versus adjuvant anti-PD-1 therapy for patients with resected, high-risk melanoma.
Cancer
; 129(14): 2117-2121, 2023 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345669
3.
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.
Cancer
; 129(12): 1904-1918, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37042037
4.
The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
N Engl J Med
; 383(7): 640-649, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32786189
5.
Lymphocyte-activation gene 3 in non-small-cell lung carcinomas: correlations with clinicopathologic features and prognostic significance.
Mod Pathol
; 35(5): 615-624, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34880448
6.
Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center.
Oncologist
; 26(8): e1427-e1433, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932247
7.
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018.
Oncologist
; 26(6): 514-522, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33655682
8.
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.
Ann Neurol
; 87(5): 659-669, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32086972
9.
Multi-detector computed tomography (MDCT)-based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitis.
Eur Radiol
; 31(12): 8868-8878, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34081152
10.
Thermal Ablation, Embolization, and Selective Internal Radiation Therapy Combined with Checkpoint Inhibitor Cancer Immunotherapy: Safety Analysis.
J Vasc Interv Radiol
; 32(2): 187-195, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33353814
11.
Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls.
Curr Oncol Rep
; 22(4): 39, 2020 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32200442
12.
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy.
Cancer
; 125(6): 884-891, 2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30521084
13.
Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas.
Mod Pathol
; 32(4): 511-523, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30367104
14.
What to Do When Anti-PD-1 Therapy Fails in Patients With Melanoma.
Oncology (Williston Park)
; 33(4): 141-8, 2019 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30990567
15.
Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP).
Cancer
; 124(11): 2407-2414, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29579334
16.
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Kidney Int
; 102(4): 930-935, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964800
17.
Case 30-2019: A 65-Year-Old Woman with Lung Cancer and Chest Pain.
N Engl J Med
; 381(13): 1268-1277, 2019 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553841
18.
Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Future Oncol
; 13(18): 1649-1663, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28776423
19.
The Art of Oncology: COVID-19 Era.
Oncologist
; 25(11): 997-1000g, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697887
20.
Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy.
Oncologist
; 25(3): e398-e404, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162817